‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’
This episode of the Venari Podcast’s Talking Radiopharma series saw Matthew Palmer speak to Ariceum Therapeutics CEO Manfred Ruediger. A serial biotech entrepreneur, Manfred has worked in executive functions in biotech for almost 25 years.
Ariceum’s development of novel targeted radiopharmaceuticals for cancer treatment – as well as Manfred’s considerable experience building out companies – certainly offered plenty of scope for discussion. Tune in to hear more about what Ariceum do differently, plus Manfred’s thoughts on team building and his advice for the radiopharmaceutical innovators of tomorrow!
Our thanks to the Ariceum CEO and his team for this fascinating podcast.
“I can say definitively that the years working abroad were the most formative from a career and personal perspective – you learn so much when you take a role outside of your home market”. Fabulous to welcome Eric Luthi, Evergreen Theragnostics’s (relatively) recently appointed Chief Commercial Officer, to the Venari Podcast. We discuss building commercial infrastructure from scratch, how international experience has shaped his career and getting into the exciting world of radiopharmaceuticals. Radiopharma is a space that my colleague Matthew Palmer and I are doing a lot of work in currently, both on the R&D and commercial side. Get in touch if you’d like to learn more!
‘I’ve always had the attitude that whatever is needed, wherever you need me to fill in, just let me know and we’ll take it on,’ says Acorda Therapeutics CCO, Kerry Clem. ‘I think that was one of the main things that helped me to elevate and grow.’ He’s amassed a wealth of commercial life sciences experience over her 25 years in the industry, joking that 13 years at Acorda alone make him ‘a relic in this industry’ – and so he was a natural candidate for inclusion on the BioPharma Chief Commercial Officer series for the Venari Podcast, run by our Life Sciences Commercial Lead, Joe Knight.
Fabrice Clerc-Renaud has had a varied career in the packaging space – and developed a product, ePack, almost as a startup within the organisation he was working for (DS Smith). Tim Hartnell, our Senior Sustainable Packaging Consultant, caught up with Fabrice on the Venari Podcast; you can find the full transcript of their interview here.
For the final episode of the Venari Podcast’s first Chief Commercial Officer series, Joe Knight, Commercial Consultant for our Life Sciences practice, spoke to Arcus Biosciences’ CCO Eric Matthews. His career has taken in some of the biggest names in the industry, tallying with a recurring theme of the series: the journey from roles in Big Pharma to a CCO position in a smaller biotech.
With over 30 years’ experience in launching and leading multi-billion-dollar blockbuster drug launches, Kirsten Detrick is more than qualified to discuss what is needed for successful commercial strategies in biopharma. She was most recently CCO at Endpoint Health, and remains sought-after by biotechs preparing for commercialisation. Kirsten spoke to our Life Sciences Commercial Consultant, Joe Knight, for the Venari Podcast Chief Commercial Officer series. Listen to their conversation which touched on Kirsten’s journey towards becoming a CCO, commercialisation and talent strategies!
‘You can’t afford to drag with suboptimal performance.’ Johanna Rossell, SVP General Manager Rare Diseases at Sumitomo Pharma America, has a wide range of professional experience to draw on when it comes to commercial biopharma. Her career has taken in stints in marketing and commercial across South America, Switzerland, and the US for a number of large companies prior to her recent experience as CCO of Enzyvant. Joe Knight, our Life Sciences Commercial Consultant, welcomed Johanna to the Venari Podcast for another episode of the Chief Commercial Officer series, where she opened up on what she’s learned from launches, when to bring in commercial teams, and her leadership philosophy of the ‘coach manager: the coach that can lead the multi-functional team’ while thinking long-term.
‘Launching a product is one of the most exciting things you can do.’ Life sciences product launches can be thrilling – if challenging. They require meticulous planning, a strong value proposition, and effective market access strategies – and Greg Gangemi knows all about this. Joe Knight, our Life Sciences Commercial Consultant, was delighted to host Greg on an episode of the Venari Podcast’s Chief Commercial Officer series.
‘What is the reason that a consumer shops with you? Focus on that, and then everything else is just noise.’ Heather Naylor has enjoyed varied experience in the retail and consumer goods space, both in industry as well as in consultancy. Mark Collins, Head of our Retail & Consumer Goods practice, has known Heather for a long time – and he was glad to catch up and get her insights in this episode of the Venari Podcast. Just about every P&L line has gone up for retailers, but Heather has plenty advice on keeping up with innovation.
How can you rebrand a popular app to reflect your company’s wider vision, while staying loyal to your customers and what brought you success in the first instance?
For Chris Wasden, CSO at Twill, the company’s mission is simple: ‘delivering the right therapy, to the right person, at the right time, in the way that they want it’.
In this fascinating interview, Chris updated us on the rebranding of healthcare app Happify into Twill, detailing how the company has expanded their outlook and what the next five years hold for them.
What are the factors that have driven the growth of telemedicine over the last years? If the recent pandemic seems to be the evident answer, Dr Harry Leider, who has been working with telemedicine for over a decade, argues that COVID doesn’t bear the sole responsibility for its exponential rise. From the various types of telemedicine companies to the limitations they face, learn from Gelesis Chief Medical Officer in this interview with Cristian Owen.
Will Christmas shoppers face empty shelves this year? Neel Jones Shah, Executive Vice President and Global Head of Airfreight at Flexport and Gov Kandola, Senior Consultant for Transport & Logistics, discussed the predicted supply chain shortages for this post-pandemic Holiday season.
Are you aiming to become a Lifestyle Brand? Are you matching the tone of voice of the brands your audience interacts with? If so, your approach is reactive.
To make sure travellers automatically answer the question “where are you staying?” with your hospitality brand's name, you should strive to become a Lifestyle Choice.
Turn into the subconscious go-to choice of your consumers by tapping into their core interests – not only into their demographics!
Jason Rieff, a multi-award-winning and Forbes-nominated 30 under 30 branding expert, answered our questions.
Learn about the difference between a Lifestyle Brand and a Lifestyle Choice, and how to become the latter.
JSR-Consultancy was founded in 2019 by Jason Rieff, a multi-award-winning and Forbes-nominated 30 under 30 branding expert. Having held C-Level and Director positions in some of the world’s largest Hospitality brands and Advertising agencies, Jason strives to provides clients with cost-effective solutions to their individual brand challenges.
Before launching JSR-Consultancy, Jason served as the Chief Marketing Officer for the global Hospitality brand Generator Hostels, overseeing the global marketing of the brand and the marketing function of the launch into the North American market.
Prior to Generator, Jason held leadership roles at an array of award-winning Advertising agencies, most recently as National Strategy Director of the German branch of the Global Social Media Agency, WeAreSocial.
In today's Surface Transport episode of the Venari Podcast, Gov Kandola met Gregory Slater, Secretary of Transportation for the Maryland Department of Transportation (MDOT). They discussed the Purple Line project, a planned 16.2-mile light rail line intended to connect the Maryland suburbs and the Washington metropolitan area, while avoiding Washington, D.C.
From the start, the Purple Line received national attention, as the first US Light rail project to rely on a mix of public and private financing. For some, it is even an example of what can go wrong with a big transit public-private partnership (P3). But is that really fair? And what are the future benefits of this line, for the wider community?
Do you know the difference between a Millennial and a Gen Zer? And is your brand doing enough to become a lifestyle choice for this new generation of consumers?
With a $150 billion consumer spend in the US alone, and $35 billion dedicated to Hospitality each year, Gen Z is the latest hot topic among marketers – or at least, it should be!
However, most luxury hospitality brands seem to struggle with this new target. The bigger the brand and its heritage, the harder it seems to adapt to Gen Zers’ new modes of consumption.
Jason Rieff, a multi-award-winning and Forbes-nominated 30 under 30 branding expert, answered our questions about these topics.
Learn about the brand offerings Millennials and Gen Zers are looking for, and how to capture younger consumers’ attention.
In this episode of the Venari Podcast, Gov Kandola, Senior Consultant in Transport, Travel & Logistics, met Lee Sander, former president for Bombardier Americas.
A couple of topics that came up during the discussion were around climate change, and our need to reduce our carbon footprint, along with issues of equity and the importance of a reliable transportation system for lower/middle income families who may not have the ability to work from home.
Lee Sander is the former President of Bombardier Transportation’s Americas Region from 2018 until the business was acquired by Alstom in January 2021. Prior to joining Bombardier, Mr. Sander was Managing Director, Global Transportation and US Infrastructure at Hatch Ltd. In addition, he held leadership roles at AECOM, notably as Group Chief Executive-Global Transportation, and at HAKS Group, where he was President and CEO.
Credited with turning around several high-profile public sector organizations in New York, he is a former Executive Director and CEO of the Metropolitan Transportation Authority, a former Commissioner of the New York City Department of Transportation, and served as a Commissioner on the New York City Taxi and Limousine Commission.
Mr. Sander served as Chairman of the Regional Plan Association and remains on the Association’s Board. From 2010 to 2021 he served on the Board of the National Express Group, most recently as Senior Independent Director. He is also Vice Chairman of the Greater Jamaica Development Corporation.
In addition, he is the founder of the Rudin Center for Transportation Policy and Management at New York University where he was also an adjunct associate professor of public policy at the Robert F. Wagner Graduate School of Public Service. He also co-founded the Empire State Transportation Alliance.
In this episode of the Venari Podcast, Gov Kandola met Lee Sander. Lee shares his insight on the post-pandemic outlook for the North American transit industry. He is the former President of Bombardier Transportation’s Americas Region and the former CEO of the New York MTA. He also served on the Board of the National Express Group, most recently as Senior Independent Director.
In this episode of the Venari Podcast, Gov Kandola, Senior Consultant in Transport, Travel & Logistics, met Lee Sander, former president for Bombardier Americas.
In this first episode of a four-part series, Lee shares his insight on the impact of the COVID-19 pandemic on the US transit and the challenges the industry will have to face to come out of this crisis.